Peter S. Nelson

66.9k citations
430 papers · 34.4k · 13 hit papers · h-index 88

Impact in

  • Cancer Research top 0.02%
    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Cancer, Lipids, and Metabolism
    • Prostate Cancer Treatment and Research
    • Prostate Cancer Diagnosis and Treatment

Papers in

Peter S. Nelson

413 papers receiving 33.7k citations

Peter S. Nelson's Hit Papers

Genomic and phenotypic heterogeneity in prostate cancer 2020 · 334 citations
3340+7+15Years since publication2.0k4.0k6.0k

Peers

Peter S. Nelson
Comparison fields: 5 of 183
  • Cancer Research 10.5k
  • Pulmonary and Respiratory Medicine 12.3k
  • Molecular Biology 15.0k
  • Oncology 5.5k
  • Endocrinology, Diabetes and Metabolism 3.1k
Replace W. Marston Linehan with:
W. Marston Linehan United States
Robert L. Vessella United States
William B. Isaacs United States
Martin Gleave Canada
Philip W. Kantoff United States
Maria J. Merino United States
Angelo M. De Marzo United States
John T. Isaacs United States
Hiroyuki Aburatani Japan
William L. Gerald United States
Peter S. Nelson relative to W. Marston Linehan United States W. Marston Linehan's profile →
Citations per field
00.5×1.5×
W. Marston Linehan · 1×
Citations per year

Countries citing papers authored by Peter S. Nelson

Since Specialization
Citations

This map shows the geographic impact of Peter S. Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Nelson more than expected).

Fields of papers citing papers by Peter S. Nelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter S. Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Nelson. The network helps show where Peter S. Nelson may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter S. Nelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter S. Nelson Line = papers co-authored together Peter S. Nelson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 430 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Circulating microRNAs as stable blood-based markers for cancer detection
Hit paper breakdown →
20086786
2
Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
Hit paper breakdown →
20081129
3
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
Hit paper breakdown →
2003873
4
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
Hit paper breakdown →
2009691
5
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
Hit paper breakdown →
2012642
6
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Hit paper breakdown →
2010593
7
Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
Hit paper breakdown →
2011483
8
Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
Hit paper breakdown →
2012463
9
Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2.
1999432
10 2007412
11
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Hit paper breakdown →
2018397
12 2002383
13
Addressing overdiagnosis and overtreatment in cancer: a prescription for change
Hit paper breakdown →
2014366
14 2011361
15 2011357
16 2006356
17
The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
Hit paper breakdown →
2014355
18 1999339
19
Genomic and phenotypic heterogeneity in prostate cancer
Hit paper breakdown →
2020334
20
In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
Hit paper breakdown →
2020332

About Peter S. Nelson

Peter S. Nelson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Endocrinology, Diabetes and Metabolism, having authored 430 papers that have together received 34.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (225 papers), Prostate Cancer Diagnosis and Treatment (51 papers), Hormonal and reproductive studies (37 papers), Cancer, Lipids, and Metabolism (35 papers), Molecular Biology Techniques and Applications (27 papers), Cancer Genomics and Diagnostics (22 papers), Radiopharmaceutical Chemistry and Applications (22 papers) and Estrogen and related hormone effects (21 papers). The work is most often cited by research in Cancer Research (10.5k citations), Pulmonary and Respiratory Medicine (12.3k citations), Molecular Biology (15.0k citations), Oncology (5.5k citations) and Endocrinology, Diabetes and Metabolism (3.1k citations). Peter S. Nelson has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Robert L. Vessella, Elahe A. Mostaghel, Ilsa M. Coleman, Bruce Montgomery, Lawrence D. True, Daniel W. Lin, Beatrice S. Knudsen, Muneesh Tewari, Daniel Martin and Patrick S. Mitchell. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, The Prostate, Clinical Cancer Research and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact